Traws Pharma launches $7.4M ATM offering under existing shelf registration

Traws Pharma, Inc.

May sell up to $7,427,749 of common stock through Citizens JMP Securities as agent/principal.
Offering under effective Form S-3 (No. 333-273081) and prospectus supplements dated March 10 and April 7, 2025.
Shares sold subject to 'baby shelf' limitation under General Instruction I.B.6. of Form S-3.
Legal opinion of Snell & Wilmer L.L.P. filed as Exhibit 5.1 to the 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.